BioNJ’s Second Annual Beyond Value Frameworks Workshop is taking place Dec. 7 at Amicus Therapeutics in Cranbury, New Jersey.
Titled “Continuing the Conversation…Seeking Solutions,” this year’s event will bring together patients, industry, payers, academia and government to discuss and contribute to the development of new platforms that will provide patients with access to the right medicines at the right time at affordable out-of-pocket costs.
“There is a lot of discussion about using value frameworks to reduce the cost of drugs and increase Patient access,” said BioNJ President and CEO Debbie Hart. “However, unfortunately, such evaluations assume that on average, everyone will respond to all drugs in the same way, when in fact, the same treatment can have different benefits to different Patients. Moreover, value frameworks are used by insurance companies to steer Patients to the least-expensive products by imposing higher cost-sharing and more barriers to obtaining recommended treatments, even if the other drugs are not as effective or oftentimes, don’t work.”